Radiotherapy with high dose rate brachytherapy boost and concomitant chemotherapy for stages IIB and III esophageal carcinoma: Results of a pilot study
Authors:
- 1 July 1997
- journal article
- clinical trial
- Published by Elsevier in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
- Vol. 38 (4) , 769-775
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Evaluation of multimodality treatment of locoregional esophageal carcinoma by Southwest Oncology Group 9060Cancer, 1996
- Preoperative chemoradiation followed by transhiatal esophagectomy for carcinoma of the esophagus: final report.Journal of Clinical Oncology, 1993
- Combined Chemotherapy and Radiotherapy Compared with Radiotherapy Alone in Patients with Cancer of the EsophagusNew England Journal of Medicine, 1992
- High-dose-rate intraluminal brachytherapy for esophageal cancer: 10 years experience in Hyogo College of MedicineRadiotherapy and Oncology, 1991
- A randomized trial comparing radiation therapy versus concomitant radiation therapy and chemotherapy in carcinoma of the thoracic esophagusCancer, 1991
- Long-term results of infusional 5-FU, mitomycin-C, and radiation as primary management of esophageal carcinomaInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1991
- Radiotherapy alone and chemoradiation for nonmetastaticCancer, 1989
- Combined therapies for squamous-cell carcinoma of the esophagus, a Southwest Oncology Group Study (SWOG-8037).Journal of Clinical Oncology, 1987
- Esophageal carcinoma: CT findings.Radiology, 1985
- Combined modality therapy for esophageal squamous cell carcinomaCancer, 1983